Top-down solution to the U.K. Orkambi debacle

Cystic fibrosis patients hope that a meeting on Monday between Vertex and the U.K. Health Secretary will break the deadlock that has prevented reimbursement of Orkambi by NHS.

If it works out, patients in England will gain access to the drug while the parties continue to hammer out an agreement on pricing -- a major step forward for one of the largest CF populations in the world, which has been locked out of the most promising treatment yet for the disease. ...